| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/18/2008 | WO2008153220A1 Prophylactic or therapeutic agent for vascular disease |
| 12/18/2008 | WO2008153207A1 Bicycloaniline derivative |
| 12/18/2008 | WO2008153182A1 Morpholine derivative |
| 12/18/2008 | WO2008153159A1 Amine compound and pharmaceutical use thereof |
| 12/18/2008 | WO2008153135A1 Naphthalene derivative |
| 12/18/2008 | WO2008153077A1 Anti-norovirus agent, and composition comprising the same |
| 12/18/2008 | WO2008153072A1 Gene sensitive to bone/joint disease and use thereof |
| 12/18/2008 | WO2008153027A1 Pyrroloquinoline derivative and use thereof |
| 12/18/2008 | WO2008151519A1 USE OF NARINGENIN AND NARINGIN AS INHIBITORS FOR TRANSFORMING GROWTH FACTOR-β1 SIGNALING PATHWAY |
| 12/18/2008 | WO2003024455A8 Stent coated with a sustained-release drug delivery and method for use thereof |
| 12/18/2008 | US20080312462 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 12/18/2008 | US20080312417 Ucp5 |
| 12/18/2008 | US20080312340 Process for Preparing Dispersions |
| 12/18/2008 | US20080312323 Inhibition of TNF-alpha-Initiated Response |
| 12/18/2008 | US20080312310 Compounds, Compositions and Methods |
| 12/18/2008 | US20080312296 Bifunctional synthetic molecules |
| 12/18/2008 | US20080312288 Solid forms of 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1h-imidazol-4-ylethynyl]-pyridine |
| 12/18/2008 | US20080312273 Quinoline Derivatives Having Vegf Inhibiting Activity |
| 12/18/2008 | US20080312266 Steroidal Compounds For Inhibiting Steroid Sulphatase |
| 12/18/2008 | US20080312249 Kmup-1 capable of treating hypertension |
| 12/18/2008 | US20080312248 Pyrimidinyl Aryl Urea Derivatives Being Fgf Inhibitors |
| 12/18/2008 | US20080312233 Therapeutic Morpholino-Substituted Compounds |
| 12/18/2008 | US20080312219 Biologically active methylene blue derivatives |
| 12/18/2008 | US20080312203 such as (5R,6Z)-6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, in combination with beta-lactam antibiotics, for the treatment of bacterial infections |
| 12/18/2008 | US20080312194 Methods and compositions for normalizing meibomian gland secretions |
| 12/18/2008 | US20080312176 Gene silencing |
| 12/18/2008 | US20080312171 Tetracycline-Dependent Regulation of Rna Interference |
| 12/18/2008 | US20080312153 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 12/18/2008 | US20080312152 Glycosylated Probnp |
| 12/18/2008 | US20080312142 Composition for Increasing Body Height |
| 12/18/2008 | US20080312141 Peptide ligands for prostate specific antigen |
| 12/18/2008 | US20080312135 Mixtures of drug-oligomer conjugates comprising polyethylene glycol, uses thereof, and methods of making same |
| 12/18/2008 | US20080312087 2-Propenal and Related Enal Compounds for Controlling Plant Pests and Weeds in Soil |
| 12/18/2008 | US20080311215 All-natural composition and method for repelling and killing insects |
| 12/18/2008 | US20080311199 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311198 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311194 Dispersible Tablets Comprising Deferasirox |
| 12/18/2008 | US20080311184 Method for developing, testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
| 12/18/2008 | US20080311181 Serum-Stable Amphoteric Liposomes |
| 12/18/2008 | US20080311177 Self Assembled Films for Protein and Drug Delivery Applications |
| 12/18/2008 | US20080311173 Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
| 12/18/2008 | US20080311156 Vaccines |
| 12/18/2008 | US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof |
| 12/18/2008 | US20080311115 Atherosclerosis, rheumatoid arthritis (RA), psoriasis, psoriatic arthritis, bacteria-induced gastric ulcer, and acute renal failure |
| 12/18/2008 | US20080311104 Stabilized thrombin compositions |
| 12/18/2008 | US20080311102 Nucleic acid molecule that encodes the MGAT-X1 protein; pharmaceutical composition containing the nucleic acid or its expression vector |
| 12/18/2008 | US20080311086 Use of Keratinocyte Composition for the Treatment of Restenosis |
| 12/18/2008 | US20080311080 Bifidobacterium in the treatment of inflammatory disease |
| 12/18/2008 | US20080311078 Self-Buffering Protein Formulations |
| 12/18/2008 | US20080311074 Inhibitors against activation of NF-kappaB |
| 12/18/2008 | US20080311040 METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA |
| 12/18/2008 | DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 12/18/2008 | DE60132178T2 CRISTALLINSALZE VON 7-i4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-iMETHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL -(3R,5S)-3,5-DIHYDROXYHEPT-6-ENSÄURE CRISTALLI SALTS OF 7-I4 (4-fluorophenyl) -6-isopropyl-2-iMETHYL (methylsulfonyl) PYRIMIDIN AMINO-5-YL - (3R, 5S) -3,5-dihydroxyhept-6-enoic acid |
| 12/18/2008 | CA2722758A1 Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof |
| 12/18/2008 | CA2690686A1 Amine compound and pharmaceutical use thereof |
| 12/18/2008 | CA2690348A1 Morpholine derivative |
| 12/18/2008 | CA2687172A1 Anti-norovirus agent and composition containing the same |
| 12/17/2008 | EP2003140A2 Galactose derivative, drug carrier and medicinal composition |
| 12/17/2008 | EP2003132A1 Hetero compound |
| 12/17/2008 | EP2003130A2 Novel pyridine derivative having anti-helicobacter pylori activity |
| 12/17/2008 | EP2002846A2 Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases |
| 12/17/2008 | EP2002839A1 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 12/17/2008 | EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/17/2008 | EP2002832A2 Composition containing lignan compound |
| 12/17/2008 | EP2002827A2 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 12/17/2008 | EP2002731A1 Use of pinolenic acid for increasing lean body mass |
| 12/17/2008 | EP2001466A2 Formulations and methods for vascular permeability-related diseases or conditions |
| 12/17/2008 | EP1641434B1 Pharmaceutical formulations for intranasal administration of protein comprising chitosan or a derivative thereof |
| 12/17/2008 | EP1503759B1 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 12/17/2008 | EP1443046B1 Novel 4-(2furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 12/17/2008 | EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 12/17/2008 | EP1423106B1 Arylsulfonyl derivatives with 5-ht 6 receptor affinity |
| 12/17/2008 | EP1395271B1 Herbal compositions for the treatment of mucosal lesions |
| 12/17/2008 | EP1385504B1 Method of inhibiting adhesion formation |
| 12/17/2008 | EP1377284B1 Controlled release arginine formulations |
| 12/17/2008 | EP1369119B1 Il-12 expression controlling agents |
| 12/17/2008 | EP1255742B1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors |
| 12/17/2008 | EP1007673B1 Novel bone mineralization proteins, dna, vectors, expression systems |
| 12/17/2008 | CN101323589A Preparation of novel compound and montelukast sodium |
| 12/17/2008 | CN101322845A Erianin inclusion compound |
| 12/17/2008 | CN101322693A Carthamus tinctorius yellow colour injection and preparation technique thereof |
| 12/17/2008 | CN101322691A Naloxone hydrochloride nano granule powder injection formulation and preparation thereof |
| 12/17/2008 | CN100443481C Imidazolyl-cyclic acetals |
| 12/17/2008 | CN100443480C Tricyclic compound and its preparation and use |
| 12/17/2008 | CN100443479C 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 12/17/2008 | CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 12/17/2008 | CN100443118C Dosages for treatment with anti-ErbB2 antibodies |
| 12/17/2008 | CN100443083C Use of aconine in medicine manufacture |
| 12/17/2008 | CN100442998C Whole wood frog powder for removing fishy smell and its health product and its production method |
| 12/16/2008 | US7465815 Cannabinoid receptor modulator |
| 12/16/2008 | US7465741 selective serotonine (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenocptor antagonist activity; To treat anxiety, movement disorders, psychosis, Parkinson's disease and body weight disorders including anorexia nervosa and bulimia without being sedative |
| 12/16/2008 | US7465737 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 12/16/2008 | US7465734 Detecting potential therapeutic agent |
| 12/16/2008 | US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity |
| 12/16/2008 | US7465713 human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; 3-(6-O-ethoxycarbonyl- beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methy]-1-isopropyl-5-methylpyrazole |
| 12/16/2008 | US7465712 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives |
| 12/16/2008 | US7465705 Immunogenic Nogo receptor-1 polypeptides, Nogo receptor-1 antibodies; diabetic neuropathy; brain injury, spinal cord injury |
| 12/16/2008 | US7465444 Methods of suppressing or treating an inflammatory bowel disease by administering an antibody or portion thereof that binds to AILIM |
| 12/16/2008 | US7465437 Delivery of anti-migraine compounds through an inhalation route |
| 12/16/2008 | US7465436 Aerosol for delivery of benzotropine, pergolide, amantadine, deprenyl, or ropinerole, formed by vaporizing the drug that is coated on a solid support and condensing the vapor to form particles containing least 10 % by weight of the drug and less than 5 % by weight of degradation products |